New information on a major player in chronic visceral leishmaniasis

October 4, 2017, Institut national de la recherche scientifique - INRS
New information on a major player in chronic visceral leishmaniasis
Credit: Institut national de la recherche scientifique - INRS

In an article in the latest issue of PLOS Pathogens, INRS professor Simona Stäger and her team show how the parasite Leishmania donovani uses a physiological response to low oxygen levels (hypoxia) to establish a chronic infection.

The parasite behind causes a chronic inflammation that enlarges the spleen and creates a hypoxic microenvironment. To compensate for the lack of oxygen and ensure their survival, cells adapt by inducing the expression of the transcription factor HIF-1α, the master regulator of the cellular response to hypoxia.

Professor Stäger and her team have demonstrated the effect of this key regulator on the function of monocytes and macrophages during viceral leishmaniasis, the most severe form of a tropical disease that affects millions of people around the world. These cells are the main targets of the parasite L. donovani

"Our lab work demonstrates that HIF-1α plays a key role in the establishment of chronic Leishmania infections by reducing the capacity of monocytes and macrophages to kill the parasite. We also found that HIF-1α gives these cells immunosuppressant properties," explains Professor Stäger.

Explore further: Mechanisms triggering excess antibody production during chronic infection

More information: Akil Hammami et al, HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006616

Related Stories

Mechanisms triggering excess antibody production during chronic infection

July 12, 2016
Some autoimmune diseases and persistent infections are characterized by high levels of antibodies in the blood. But what are the causes of this hypergammaglobulinemia? A team headed by INRS's Professor Simona Stäger has ...

Meeting a microbe in the morning or in the evening: Is it all the same?

September 8, 2017
Does the time of day matter when our body is infected by a parasite? According to new research from McGill University, it matters a great deal.

How the leishmania parasite sabotages the immune response

October 12, 2016
An international collaborative of researchers has identified a mechanism that allows the leishmania parasite, which causes leishmaniasis, to evade the immune system and thereby produce infection. The study, published in Immunity, ...

Recommended for you

Largest oral HPV study in England shows infection rates lower than expected

August 20, 2018
Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.